Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 276.11M P/E - EPS this Y 21.10% Ern Qtrly Grth -
Income -101.17M Forward P/E -3.95 EPS next Y - 50D Avg Chg -12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 21.00%
Dividend N/A Price/Book 4.11 EPS next 5Y - 52W High Chg -32.00%
Recommedations 2.00 Quick Ratio 5.02 Shares Outstanding 167.94M 52W Low Chg 168.00%
Insider Own 0.83% ROA -44.38% Shares Float 130.20M Beta 0.46
Inst Own 61.32% ROE -161.67% Shares Shorted/Prior 12.33M/14.40M Price 1.74
Gross Margin - Profit Margin - Avg. Volume 3,643,658 Target Price 3.55
Oper. Margin - Earnings Date May 2 Volume 1,671,654 Change 0.00%
About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

X4 Pharmaceuticals, Inc. News
04/11/24 X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) market cap decline of US$42m may not have as much of an impact on institutional owners after a year of 7.0% returns
04/02/24 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/24 XFOR: PDUFA Date of April 30, 2024 for Mavorixafor for WHIM Syndrome…
04/01/24 X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
03/22/24 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 X4 Pharmaceuticals Inc Earnings Call
03/21/24 X4 Pharmaceuticals Inc (XFOR) Reports Fourth-Quarter and Full-Year 2023 Financial Results
03/21/24 X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
03/12/24 X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
12/15/23 XFOR: Update on Phase 2 CN Trial at ASH 2023
12/09/23 X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
11/13/23 XFOR: Mavorixafor NDA Accepted by FDA; PDUFA Date of April 30, 2024
11/10/23 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2023 Earnings Call Transcript
11/10/23 X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences
11/10/23 Q3 2023 X4 Pharmaceuticals Inc Earnings Call
11/09/23 X4 Pharmaceuticals Inc (XFOR) Reports Q3 2023 Financial Results and Corporate Progress
11/09/23 X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
11/03/23 With 58% ownership of the shares, X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is heavily dominated by institutional owners
11/02/23 X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023
10/31/23 X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome
XFOR Chatroom

User Image GoldenAlerts Posted - 19 minutes ago

$XFOR Added today

User Image Billy_Tran Posted - 3 hours ago

$XFOR Not financial advice, just messing around with the chart,

User Image DS121212 Posted - 3 hours ago

$XFOR see previous post. Everything you think you know or talk about is meaningless. Prices go far beyond any rational though or reason. News means nothing. It’s whatever people with far more power than all of combined want to happen. Then sooner we all figure out that we mean nothing, the better.

User Image Motleyorc Posted - 3 hours ago

$XFOR Bought 2250 more shares at 1.20

User Image ScoutingVolume Posted - 4 hours ago

$XFOR added here

User Image boomshiva Posted - 4 hours ago

$XFOR This one hurt today. Isn't behaving like it's 13 days out from a positive PDUFA.

User Image CLIVOPTO Posted - 4 hours ago

$XFOR I’m in with 20,800 Shares… todays dip helped me acquire 🙏

User Image buymoremakemore Posted - 4 hours ago

$XFOR someone trying to get in for cheap???

User Image buymoremakemore Posted - 5 hours ago

$XFOR i say that this is going to go up before PDUFA decision. I say $1.40 is not out of the question. But definitely there will be a lot of volatility. So if youre not long, dont get too greedy. The last 2 days especially

User Image Bullbigballs Posted - 6 hours ago

$XFOR just bought in, good or bad move?

User Image Bornjever Posted - 7 hours ago

$XFOR this is the new way big players work is they drive price down and especially companies like AKBA and XFOR and even though AKBA has good sales already and close to profit on earnings with increase to 6.00 per share projection they drive it down to .50 if they can because retail and newbies will sell and price in toilet but this earnings will show strong for AKBA and next will go to 4.00.

User Image Say_Whaaaat Posted - 7 hours ago

$XAIR I downsized here to almost nothing. Moved out into $xfor for pdufa and ph3 readout. I feel it in my nuggets. Xair is dead until at least August earnings

User Image Rollercoaster22 Posted - 10 hours ago

$XFOR Same procedure every day. When will the manipulation come to an end?

User Image Pangloss_0589 Posted - 10 hours ago

$XFOR and there it starts again, ensuring that this thing doesn't get near 1.5. A few hours of that a day and then they let it go to 1.3, repeat process until friday

User Image RallyRaider Posted - 11 hours ago

$XFOR looking for a 20-30ct gain Very pretty chart.

User Image Rollercoaster22 Posted - 19 hours ago

$XFOR I feel

User Image MoneyMakinManhattan Posted - 19 hours ago

$XFOR she's been up about 50% over the last month...how much does she have left for us before approval.

User Image TraderToms Posted - 22 hours ago

$XFOR coming soon 👇

User Image RallyRaider Posted - 23 hours ago

$XFOR very pretty chart and story seems sound. looking for some 30 cents

User Image Night2 Posted - 1 day ago

$XFOR

User Image buymoremakemore Posted - 1 day ago

$XFOR nice close for low(ish) volume

User Image DebWater_ Posted - 1 day ago

$XFOR The Boston Marathon maybe finished. But Xfor is not done running yet. Do not toss away your sneakers yet. Weeeeeee

User Image ChicagoBull0780 Posted - 1 day ago

$XFOR hey Cletus she's just getting started...

User Image ChicagoBull0780 Posted - 1 day ago

$XFOR some nerd got on my page trying to hate on a playa foreal lol.. I like this play all day up here, forget what u heard. CHOCx2 BOSx1 typically means one thing, higher prices. Freebie chart cause I'm nice like that

User Image RetiredGuy68 Posted - 1 day ago

$XFOR After a year’s worth of accumulation, I’m ready to sell half of my shares for $1.30. Decent profit plus practicing risk management at this point.

User Image Billy_Tran Posted - 1 day ago

$XFOR haha attention are elsewhere right now, market got crazy news this past few days, this will get its attention next week when its close of fda approval, avg at .90 loaded more, now avg 1.15 haha riding this either so sub .90 or 1.50+

User Image MoneyMakinManhattan Posted - 1 day ago

$XFOR tired of this price action...

User Image buymoremakemore Posted - 1 day ago

$XFOR several other tickers with pdufas before this are down too. Aqst ibrx etc etc

User Image buymoremakemore Posted - 1 day ago

$XFOR 2 weeks from today. Any day now this could be back at 1.50

User Image ChicagoBull0780 Posted - 1 day ago

$XFOR should run today. Dead below 1.25 Target 1.4 Swing 1.6

Analyst Ratings
HC Wainwright & Co. Buy Mar 22, 24
B. Riley Securities Neutral Dec 12, 23
HC Wainwright & Co. Buy Aug 11, 23
Stifel Buy May 17, 23
HC Wainwright & Co. Buy May 5, 23
B. Riley Securities Buy Apr 10, 23
Oppenheimer Outperform Mar 24, 23
Cantor Fitzgerald Overweight Mar 22, 23
HC Wainwright & Co. Buy Mar 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ragan Paula President and CEO President and CEO Nov 01 Sell 0.82 239,437 196,338 836,441 11/03/23
WYZGA MICHAEL S Director Director Aug 18 Buy 1.195 25,000 29,875 76,667 08/22/23
Stewart Murray Interim Chief Medica.. Interim Chief Medical Officer Aug 09 Sell 1.06 130,056 137,859 146,504 08/11/23
Ragan Paula President and CEO President and CEO May 31 Sell 1.95 6,292 12,269 557,245 05/31/23
Ragan Paula President and CEO President and CEO Jun 03 Sell 1.21 6,292 7,613 661,806 06/06/22